Israel and US-based medical device company V-Wave has closed a $28m series B round featuring Johnson & Johnson Innovation, the investment unit of pharmaceutical firm Johnson & Johnson, and medical equipment manufacturer Edwards Lifesciences.

TriVentures, Pura Vida Investments, BRM Capital, BioStar Ventures and Pontifax also participated in the round.

Founded in 2010, V-Wave is working on a minimally invasive device to treat patients suffering from chronic symptomatic heart failure. The company hopes the device, dubbed V-Wave Unidirectional Shunt System, will…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?